DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31

QUEST DIAGNOSTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026

$234.91−0.09 (-0.04%)

Close on Oct 19, 2026

Community

Notes and questions about Quest Diagnostics from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Quest Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 21, 2005
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is DGX.

Revenue growth9.9% · median 18.9%

Gross margin33.1% · median 28.9%

Operating margin14.1% · median -0.4%

Net margin9.2% · median -3.2%

Advertisement
300 × 250